Peniel Sciences committed to saving lives through innovative technological breakthroughs. The company is focused primarily on leveraging the use of peptides and related biomolecules such as oligonucleotides as pharmaceutical and cosmetic ingredients. Peniel sciences is developing several innovative technologies in these potential areas.

Our mission is to bring peptide and related biomedicines to market rapidly to address various global health issues.

Our management team has several decades of cumulative experience in the field of drug discovery, drug development, CMC development and large scale manufacturing. This includes small molecules, peptides, proteins, oligonucleotides and bio-conjugates. Moreover, the founding members have experience in biomedical investment management, forging business partnerships, technology transfer, product/process licensing and regulatory aspects of medical device industry.